Gene-based treatments are reshaping cancer care!
The #CancerGeneTherapy market will reach USD 32 Billion by 2035 at a 13.37% CAGR.
Leading the charge: 🔹@Novartis 🔹@Pfizer 🔹@Bluebirdbio
#GeneTherapy #Oncology #PrecisionMedicine #Biotech #HealthInnovation
www.einpresswire.com/article/8054....
The #CancerGeneTherapy market will reach USD 32 Billion by 2035 at a 13.37% CAGR.
Leading the charge: 🔹@Novartis 🔹@Pfizer 🔹@Bluebirdbio
#GeneTherapy #Oncology #PrecisionMedicine #Biotech #HealthInnovation
www.einpresswire.com/article/8054....
Cancer Gene Therapy Market Expected to Achieve a Strong 13.37% CAGR, to Reach USD 32.0 Billion by 2035
Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration.
www.einpresswire.com
October 13, 2025 at 7:29 AM
Gene-based treatments are reshaping cancer care!
The #CancerGeneTherapy market will reach USD 32 Billion by 2035 at a 13.37% CAGR.
Leading the charge: 🔹@Novartis 🔹@Pfizer 🔹@Bluebirdbio
#GeneTherapy #Oncology #PrecisionMedicine #Biotech #HealthInnovation
www.einpresswire.com/article/8054....
The #CancerGeneTherapy market will reach USD 32 Billion by 2035 at a 13.37% CAGR.
Leading the charge: 🔹@Novartis 🔹@Pfizer 🔹@Bluebirdbio
#GeneTherapy #Oncology #PrecisionMedicine #Biotech #HealthInnovation
www.einpresswire.com/article/8054....
Explore 20 years of #gendicine rAd-p53, the first-in-class #cancergenetherapy. Discover how TP53-targeted strategies are revolutionizing personalized #oncology with groundbreaking clinical insights.
#openaccess : https://buff.ly/4jwyGGw
#genetherapy #cancerresearch #openaccessjournal
#openaccess : https://buff.ly/4jwyGGw
#genetherapy #cancerresearch #openaccessjournal
Twenty years of Gendicine® rAd p53 Cancer Gene Therapy
Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology.Learn more: https://...
buff.ly
January 24, 2025 at 7:00 PM
Explore 20 years of #gendicine rAd-p53, the first-in-class #cancergenetherapy. Discover how TP53-targeted strategies are revolutionizing personalized #oncology with groundbreaking clinical insights.
#openaccess : https://buff.ly/4jwyGGw
#genetherapy #cancerresearch #openaccessjournal
#openaccess : https://buff.ly/4jwyGGw
#genetherapy #cancerresearch #openaccessjournal